Aquilo Capital Management
Latest statistics and disclosures from Aquilo Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, IWM, SPRO, BPMC, DRNA, and represent 85.86% of Aquilo Capital Management's stock portfolio.
- Added to shares of these 7 stocks: IWM (+$255M), XBI (+$223M), SPRO (+$29M), BPMC (+$6.6M), MGTA (+$6.5M), ACIU, GMAB.
- Started 4 new stock positions in GMAB, ACIU, MGTA, IWM.
- Reduced shares in these 10 stocks: ARGX (-$7.4M), PIRS, MOR, QURE, ARWR, ANAB, GLPG, DRNA, NGM, RGNX.
- Sold out of its positions in MOR.
- Aquilo Capital Management was a net buyer of stock by $498M.
- Aquilo Capital Management has $945M in assets under management (AUM), dropping by 90.48%.
Tip: Access up to 7 years of quarterly data
Positions held by Aquilo Capital Management, LLC consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Aquilo Capital Management
Companies in the Aquilo Capital Management portfolio as of the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Spdr Ser Tr S&p Biotech Unit Put Option (XBI) | 47.2 | $446M | +100% | 4.0M | 111.43 | |
Ishares Tr Russell 2000 Etf Unit Put Option (IWM) | 27.0 | $255M | NEW | 1.7M | 149.79 | |
Spero Therapeutics (SPRO) | 5.3 | $50M | +131% | 4.5M | 11.16 | |
Blueprint Medicines (BPMC) | 3.8 | $36M | +22% | 386k | 92.70 | |
Dicerna Pharmaceuticals (DRNA) | 2.6 | $25M | -5% | 1.4M | 17.99 | |
Uniqure Nv SHS (QURE) | 2.5 | $23M | -7% | 631k | 36.83 | |
Arrowhead Pharmaceuticals (ARWR) | 2.4 | $23M | -7% | 523k | 43.06 | |
Anaptysbio Inc Common (ANAB) | 2.3 | $22M | -7% | 1.5M | 14.75 | |
Ngm Biopharmaceuticals (NGM) | 1.7 | $16M | -7% | 1.0M | 15.91 | |
Regenxbio Inc equity us cm (RGNX) | 1.5 | $14M | -7% | 511k | 27.52 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 1.2 | $11M | -4% | 2.3M | 4.79 | |
Pieris Pharmaceuticals (PIRS) | 0.8 | $7.6M | -34% | 3.7M | 2.07 | |
Magenta Therapeutics (MGTA) | 0.7 | $6.5M | NEW | 959k | 6.80 | |
Galapagos Nv Spon Adr (GLPG) | 0.5 | $4.6M | -26% | 33k | 141.91 | |
Setup an alertAquilo Capital Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified? |
||||||
Ac Immune Sa SHS (ACIU) | 0.2 | $2.3M | NEW | 464k | 4.88 | |
Argenx Se Sponsored Adr (ARGX) | 0.2 | $2.0M | -79% | 7.5k | 262.53 | |
Genmab A/s Sponsored Ads (GMAB) | 0.2 | $1.8M | NEW | 50k | 36.62 |
Past Filings by Aquilo Capital Management
SEC 13F filings are viewable for Aquilo Capital Management going back to 2018
- Aquilo Capital Management 2020 Q3 filed Nov. 16, 2020
- Aquilo Capital Management 2020 Q2 filed Aug. 14, 2020
- Aquilo Capital Management 2020 Q1 filed May 15, 2020
- Aquilo Capital Management 2019 Q4 filed Feb. 14, 2020
- Aquilo Capital Management 2019 Q3 filed Nov. 14, 2019
- Aquilo Capital Management 2019 Q2 filed Aug. 14, 2019
- Aquilo Capital Management 2019 Q1 filed May 15, 2019
- Aquilo Capital Management 2018 Q4 filed Feb. 14, 2019